Keeping Up with Medical Device Cybersecurity

NetSPI offers three best practices for making third-party pentest data compatible with security orchestration, since static PDF reports and custom formats hinder automated correlation and remediation.

Section 3305 of the 2023 Omnibus requires medical device makers to submit plans to the FDA for monitoring and addressing device cyber vulnerabilities, backed by $5 million in FDA funding.

Citing CEO survey data and breach costs, NetSPI makes the case for PTaaS: continuous manual-plus-automated testing on a monthly or quarterly cadence instead of annual point-in-time penetration tests.

Six ways to close the gap between technical vulnerability reports and business stakeholders: know the business, brief vendors properly, design executive reporting up front, and add business context.

NetSPI lists five signs of an overly manual application security assessment process, from email scoping to copy-paste reporting, arguing automation can cut administrative overhead by 40-60%.

NetSPI explains how multiple scanners and ticketing systems create data silos that breed duplicate vulnerabilities and false positives, slowing remediation and eroding trust in security testing.